果蝇在肿瘤学研究中的优势及应用前景

doi:10.3724/SP.J.1005.2014.00030

[an error occurred while processing this directive]

HEREDITAS ›› 2014, Vol. 36 ›› Issue (1): 30-40.doi: 10.3724/SP.J.1005.2014.00030

Previous Articles Next Articles

The applications and advantages of Drosophila melanogaster in cancer research

Guitao Huo, Jianjun Lu, Zhe Qu, Zhi Lin, Di Zhang, Yanwei Yang, Bo Li

National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China

Received:2013-06-26 Revised:2013-10-21 Online:2014-01-20 Published:2013-12-20

Abstract

Abstract:

The common fruit fly, Drosophila melanogaster, has been used to study human disease as a model organism for many years. Many basic biological, physiological, and neurological properties are conserved between mammals and fly. Moreover, Drosophila melanogaster has its unique advantage as a model organism. Recent studies showed that the high level of signaling pathway conservation in tumorigenesis between fly and human and its feasible genetic operation make fly an effective model for oncology research. Numerous research findings showed Drosophila melanogaster was an ideal model for studying the molecular mechanisms of tumorigenesis, invasion and metastasis. This review mainly focuses on the advantages of Drosophila melanogaster in cancer research, established models used for the research of specific cancers and prospective research direction of oncology. It is hoped that this paper can provide insight for cancer research and development of anti-cancer drugs.

Key words: Drosophila melanogaster, tumor, human disease, model

Guitao Huo, Jianjun Lu, Zhe Qu, Zhi Lin, Di Zhang, Yanwei Yang, Bo Li. The applications and advantages of Drosophila melanogaster in cancer research[J]. HEREDITAS, 2014, 36(1): 30-40.

References

[1] Moloney A, Sattelle DB, Lomas DA, Crowther DC. Alz-heimer’s disease: insights from Drosophila melanogaster models. Trends in Biochemical Sciences, 2009, 35(4): 228–235. <\p>

[2] Feany MB, Bender WW. A Drosophila model of Parkinson’s disease. Nature, 2000, 404(6776): 394–398. <\p>

[3] Wolfgang WJ, Miller TW, Webster JM, Huston JS, Thompson LM, Marsh JL, Messer A. Suppression of Hun-tington’s disease pathology in Drosophila by human sin-gle-chain Fv antibodies. Proc Natl Acad Sci USA, 2005, 102(32): 11563–11568. <\p>

[4] Thackray AM, Muhammad F, Zhang C, Di Y, Jahn TR, Landgraf M, Crowther DC, Evers JF, Bujdoso R. Ovine PrP transgenic Drosophila show reduced locomotor acti¬vity and decreased survival. Biochem J, 2012, 444(3): 487– 495. <\p>

[5] St Johnston D. The art and design of genetic screens: Drosophila melanogaster. Nat Rev Genet, 2002, 3(3): 176–188. <\p>

[6] Pandey UB, Nichols CD. Human disease models in Dro-sophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev, 2011, 63(2): 411–436. <\p>

[7] Satta R, Dimitrijevic N, Manev H. Drosophila metabolize 1, 4-butanediol into gamma-hydroxybutyric acid in vivo. Eur J Pharmacol, 2003, 473(2?3): 149–152. <\p>

[8] Wolf FW, Heberlein U. Invertebrate models of drug abuse. J Neurobiol, 2003, 54(1): 161–178. <\p>

[9] Andretic R, Kim YC, Jones FS, Han KA, Greenspan RJ. Drosophila D1 dopamine receptor mediates caffeine- induced arousal. Proc Natl Acad Sci USA, 2008, 105(51): 20392–20397. <\p>

[10] Lloyd TE, Taylor JP. Flightless flies: Drosophila models of neuromuscular disease. Ann NY Acad Sci, 2010, 1184: e1–e20. <\p>

[11] Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. A systematic analysis of human disease-associated gene se-quences in Drosophila melanogaster. Genome Res, 2001, 11(6): 1114–1125. <\p>

[12] Wassarman DA, Therrien M, Rubin GM. The Ras signaling pathway in Drosophila. Curr Opin Genet Dev, 1995, 5(1): 44–50. <\p>

[13] Oro AE, Higgins KM, Hu ZL, Bonifas JM, Epstein EH Jr, Scott MP. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science, 1997, 276(5313): 817–821. <\p>

[14] Dahmane N, Lee J, Robins P, Heller P, Ruizi AA. Activation of the transcription factor Gli1 and the sonic hedgehog signalling pathway in skin tumours. Nature, 1997, 389(6653): 876–881. <\p>

[15] Gonzalez C. Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer, 2013, 13(3): 172–183. <\p>

[16] Ranganathan P, Weaver KL, Capobianco AJ. Notch signaling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer, 2011, 11(5): 338–351. <\p>

[17] Espinoza I, Pochampally R, Xing F, Watabe K, Miele L. Notch signaling: targeting cancer stem cells and epitheli-al-to-mesenchymal transition. Onco Targets Ther, 2013, 6: 1249–1259. <\p>

[18] Malinge S, Ben-Abdelali R, Settegrana C, Radford-Weiss I, Debre M, Beldford K, Macintyre EA, Villeval JL, Vainchenker W, Berger R, Bernard OA, Delabesse E, Pe-nard-Lacronique V. Novel activating JAK2 mutation in a patient with Down syndrome and B-cell Precursor acute lymphoblastic leukemia. Blood, 2007, 109(5): 2202–2204. <\p>

[19] Harrison DA, Binari R, Nahreini TS, Gilman M, Perrimon N. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J, 1995, 14(12): 2857–2865. <\p>

[20] Vainchenker W, Dusa A, Constantinescu SN. JAKs in pa-thology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies. Semin Cell Dev Biol, 2008, 19(4): 385–393. <\p>

[21] Polakis

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

The applications and advantages of Drosophila melanogaster in cancer research

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Qingyu Sun, Yang Zhou, Lijuan Du, Mengke Zhang, Jiale Wang, Yuanyuan Ren, Fang Liu. Analysis between macrophage-related genes with prognosis and tumor microenvironment in non-small cell lung cancer [J]. Hereditas(Beijing), 2023, 45(8): 684-699.
[2]	Chenghao Yan, Weiyu Bai, Zhimeng Zhang, Junling Shen, Youjun Wang, Jianwei Sun. The roles and mechanism of STIM1 in tumorigenesis and metastasis [J]. Hereditas(Beijing), 2023, 45(5): 395-408.
[3]	Chunhui Ma, Haixu Hu, Lijuan Zhang, Yi Liu, Tianyi Liu. Establishment and verification of a digital PCR assay for the detection of CK19 expression in quantitative analysis of circulating tumor cell [J]. Hereditas(Beijing), 2023, 45(3): 250-260.
[4]	Dong Chang, Xiangxiang Liu, Rui Liu, Jianwei Sun. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression [J]. Hereditas(Beijing), 2023, 45(2): 115-127.
[5]	Zhichen Tian, Xiaojuan Yin. Advances in the application of induced pluripotent stem cells in pediatric diseases [J]. Hereditas(Beijing), 2023, 45(1): 42-51.
[6]	Fei Gao, Yu Wang, Jiaxiang Du, Xuguang Du, Jianguo Zhao, Dengke Pan, Sen Wu, Yaofeng Zhao. Advances and applications of genetically modified pig models in biomedical and agricultural field [J]. Hereditas(Beijing), 2023, 45(1): 6-28.
[7]	Qinggang Hao, Fenggui Sun, Chenghao Yan, Jianwei Sun. Progress on the role and mechanism of MT1-MMP in tumor metastasis [J]. Hereditas(Beijing), 2022, 44(9): 745-755.
[8]	Yan Zhao, Chenxin Wang, Tianming Yang, Chunshuang Li, Lihong Zhang, Dongni Du, Ruoxi Wang, Jing Wang, Min Wei, Xueqing Ba. Linking oxidative DNA lesion 8-OxoG to tumor development and progression [J]. Hereditas(Beijing), 2022, 44(6): 466-477.
[9]	Mengxiao Wang, Margaret S. Ho. Recent advances on the role of glia in physiological behaviors: insights from Drosophila melanogaster [J]. Hereditas(Beijing), 2022, 44(4): 300-312.
[10]	Haoliang Cui, Peihua Shi, Jinchun Gao, Xinbo Zhang, Shunran Zhao, Chenyu Tao. Progress on the study of nucleosome reorganization during cellular reprogramming [J]. Hereditas(Beijing), 2022, 44(3): 208-215.
[11]	Min Cheng, Jing Zhang, Pengbo Cao, Gangqiao Zhou. Prognostic and predictive value of the hypoxia-associated long non-coding RNA signature in hepatocellular carcinoma [J]. Hereditas(Beijing), 2022, 44(2): 153-167.
[12]	Changgui Lei, Xueyuan Jia, Wenjing Sun. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database [J]. Hereditas(Beijing), 2021, 43(7): 665-679.
[13]	Yanni Kou, Shan Cen, Xiaoyu Li. Research and application on LINE-1 in diagnosis and treatment of tumorigenesis [J]. Hereditas(Beijing), 2021, 43(6): 571-579.
[14]	Zhuo Wang, Xiaohan Shen, Qihui Shi. Advances in single-cell whole genome sequencing technology and its application in biomedicine [J]. Hereditas(Beijing), 2021, 43(2): 108-117.
[15]	Yansen Zheng, Lingang Zhuo, Dali Li, Mingyao Liu. Inflammatory bowel disease susceptible gene GPR35 promotes bowel inflammation in mice [J]. Hereditas(Beijing), 2021, 43(2): 169-181.